SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001387131-21-009556
Filing Date
2021-09-21
Accepted
2021-09-21 16:33:04
Documents
2
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP vrpx-sc13g_091421.htm SC 13G 75878
2 JOINT ACQUISITION STATEMENT ex1.htm EX-1 8292
  Complete submission text file 0001387131-21-009556.txt   85784
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Subject) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92861 | Film No.: 211266875
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 W 57 ST FL20 NEW YORK NY 10019
Business Address 152 W 57 ST FL20 NEW YORK NY 10019 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G